Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  Zhang, Li ^a   Frederich, Markus ^a,c   He, Huamei ^a   Balschi, James A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BLI 247 ^*  (United States)

^c UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

5 aminoimidazole 4 carboxamide 1 D riboside; Acetyl CoA carboxylase; Signal transduction

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE; MULTIENZYME COMPLEX; PROTEIN SERINE THREONINE KINASE; RIBONUCLEOSIDE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART; HEART PERFUSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UREA CYCLE; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; HEART MUSCLE; IN VITRO STUDY; METABOLISM;

ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MULTIENZYME COMPLEXES; MYOCARDIUM; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEOSIDES;

EID: 33645730144     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00906.2005     Document Type: Article

References (30)

1. Balschi JA, Shen H, Madden MC, Hai JO, Bradley EL Jr, and Wolkowicz PE. Model systems for modulating the free energy of ATP hydrolysis in normoxically perfused rat hearts. J Mol Cell Cardiol 29: 3123-3133, 1997.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
3. 31P NMR Bayesian spectral analysis of rat brain in vivo. Magn Reson Med 9: 282-287, 1989.
4. Corton JM, Gillespie JG, Hawley SA, and Hardie DG. 5-Aminoimidazole-4- carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
5. Dagher Z, Ruderman N, Tornheim K, and Ido Y. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem Biophys Res Commun 265: 112-115, 1999. [Corrigenda. Biochem Biophys Res Commun 266: December, 1999, p. 615.]
6. Davies SP, Helps NR, Cohen PT, and Hardie DG. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Cα and native bovine protein phosphatase-2AC. FEBS Lett 377: 421-425, 1995.
7. Frederich M and Balschi JA. The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J Biol Chem 277: 1928-1932, 2002.
8. Frederich M, Zhang L, and Balschi JA. Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart. Am J Physiol Heart Circ Physiol 288: H2412-H2421, 2005.
9. Fryer LGD, Parbu-Patel A, and Carling D. Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino-4 imidazolecarboxamide riboside. FEBS Lett 531: 189-192, 2002.
10. Hardie DG and Carling D. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997.
11. Hardie DG, Carling D, and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
12. Hardie DG, Salt IP, Hawley SA, and Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338: 717-722, 1999.
13. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, and Hardie DG. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol Chem 2: 28, 2003.
14. 2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270: 27186-27191, 1995.
15. Henderson JF, Paterson AR, Caldwell IC, Paul B, Chan MC, and Lau KF. Inhibitors of nucleoside and nucleotide metabolism. Cancer Chemother Rep 2 3: 71-85, 1972.
16. Henin N, Vincent MF, Gruber HE, and Van den Berghe G. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J 9: 541-546, 1995.
17. Holmes BF, Kurth-Kraczek EJ, and Winder WW. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87: 1990-1995, 1999.
18. Javaux F, Vincent MF, Wagner DR, and van den Berghe G. Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells. Biochem J 305: 913-919, 1995.
19. eq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem 254: 6528-6537, 1979.
20. Longnus SL, Wambolt RB, Parsons HL, Brownsey RW, and Allard MF. 5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am J Physiol Regul Integr Comp Physiol 284: R936-R944, 2003.
21. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
22. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
23. Russell RR III, Bergeron R, Shulman GI, and Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277: H643-H649, 1999.
24. Sabina RL, Kernstine KH, Boyd RL, Holmes EW, and Swain JL. Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle. Effects on purine nucleotide synthesis. J Biol Chem 257: 10178-10183, 1982.
25. Safer B, Smith CM, and Williamson J. Control of the transport of reducing equivalents across the mitochondrial membrane in perfused rat heart. J Mol Cell Cardiol 2: 111-124, 1971.
26. Schulz H. Inhibitors of fatty acid oxidation. Life Sci 40: 1443-1449, 1987.
27. Swain JL, Hines JJ, Sabina RL, and Holmes EW. Accelerated repletion of ATP and GTP pools in postischemic canine myocardium using a precursor of purine de novo synthesis. Circ Res 51: 102-105, 1982.
28. Vincent MF, Bontemps F, and Van den Berghe G. Substrate cycling between 5-amino-4-imidazolecarboxamide riboside and its monophosphate in isolated rat hepatocytes. Biochem Pharmacol 52: 999-1006, 1996.
29. Vincent MF, Marangos PJ, Gruber HE, and Van den Berghe G. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 40: 1259-1266, 1991.
30. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, and Holloszy JO. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88: 2219-2226, 2000.